References
- Plante J. Évaluation des programmes. Quebec City (QC): Presses de l’Université Laval; 1994.
- Public Health Agency of Canada [Internet]. Ottawa (ON): Canadian Immunization Guide. [cited 2019 Mar 30]. Available from: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-1-key-immunization-information.html
- Piso B, Wild C. Decision support in vaccination policies. Vaccine. 2009;27(43):5923–5928.
- Burchett HE, Mounier-Jack S, Griffiths UK, et al. National decision-making on adopting new vaccines: a systematic review. Health Policy Plan. 2012;27(Suppl. 2):ii62–76.
- González-Lorenzo M, Piatti A, Coppola L, et al. Conceptual frameworks and key dimensions to support coverage decisions for vaccines. Vaccine. 2015;33(9):1206–1217.
- Kingdon JW. Agendas, alternatives and public policies. Updated 2nd ed. Glenview (IL): Longman-Pearson; 1984.
- Ismail SJ, Langley JM, Harris TM, et al. Canada’s National Advisory Committee on Immunization (NACI): evidence-based decision-making on vaccines and immunization. Vaccine. 2010;28S:A58–A63.
- De Wals P. Optimizing the acceptability, effectiveness and costs of immunization programs: the Quebec experience. Exp Rev Vaccines. 2011;10:55–62.
- Bryson M, Duclos P, Jolly A, et al. A global look at national immunization technical advisory groups. Vaccine. 2010;28(suppl 1):A13–A17.
- Nohynek H, Wichmann O, D’Ancona F, et al. National Advisory Groups and their role in immunization policy-making processes in European countries. Clin Microbiol Infect. 2013;19(12):1096–1105.
- Ricciardi GW, Toumi M, Weil-Olivier C, et al. Comparison of NITAG policies and working processes in selected developed countries. Vaccine. 2015;33(1):3–11.
- Burchett HED, Mounier-Jack S, Griffiths UK, et al. New vaccine adoption: qualitative study of national decision-making processes in seven low-and middle-income countries. Health Policy Plan. 2012;27(suppl2):ii5–ii16.
- Wenger JD, Difabio J, Landaverde JM, et al. Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four ‘newly adopting’ countries. Vaccine. 1999;18:736–742.
- Munira SL, Fritzen SA. What influences government adoption of vaccines in developing countries? A policy process analysis. Soc Sci Med. 2007;65:1751–1764.
- Erickson LJ, De Wals P, Farand L. An analytical framework for immunization programs in Canada. Vaccine. 2005;23(19):2470–2476.
- Comité sur l’immunisation du Québec. Scientific advisory on the optimal schedule for childhood immunization against pneumococcal disease in Quebec. Quebec City (QC): Institut national de santé publique; 2018. Available from: https://www.inspq.qc.ca/sites/default/files/publications/2379_opinion_optimal_schedule_childhood_immunization_pneumococcal_disease.pdf
- Comité sur l’immunisation du Québec. Utilisation des vaccins pneumococciques conjugués 10 et 13-valent dans les différents groupes d’âge. Quebec City (QC): Institut national de santé publique; 2019. Available from: https://www.inspq.qc.ca/sites/default/files/publications/2389_utlisation_vaccins_pneumococciques_10_13_valent.pdf
- Weible CM, Sabatier PA. Theories of the policy process. London (UK): Westview Press; 2018.
- Béland D. Kingdon reconsidered: ideas, interests and institutions in comparative policy analysis. J Comp Policy Anal. 2016;18(3):228–242.
- Plotkin SL, Plotkin SA. A short history of vaccination. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th ed. Philadelphia (PA): Elsevier; 2013. p. 1–13.
- Douglas RG, Samant VB. The vaccine industry. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th ed. Philadelphia (PA): Elsevier; 2013. p. 44–57.
- Stratton KR, Durch JS, Lawrence RS. Vaccines for the 21st Century: A tool for decision-making. Washington (DC): National Academies Press; 2000.
- National Advisory Committee on Immunization. Evidence-based recommendations for immunization – methods of the National Advisory Committee on Immunization. Can Commun Dis Rep. 2009;35(ACS–1):1–10.
- Lee G, Carr W. ACIP evidence-based recommendations work group. Updated framework for development of evidence-based recommendations by the advisory committee on immunization practices. Mmwr. 2018;67:1271–1272.
- World Health Organization (WHO). Health topics: public health surveillance. Geneva: WHO; 2018. Available from: http://www.who.int/topics/public_health_surveillance/en/
- Valiquette L, Low DE, Pépin J, et al. Clostridium difficile infection in hospitals: a brewing storm. CMAJ. 2004;171(1):27–29.
- Morrow A, De Wals P, Petit G, et al. The burden of pneumococcal disease in the Canadian population before routine use of the seven-valent pneumococcal conjugate vaccine. Can J Infect Dis Med Microbiol. 2007;18(2):121–127.
- Slovic P. Perception of risk. Science. 1987;236(4799):280–285.
- Ekos Research Associates Inc. Survey of parents on key issues related to immunization. Ottawa (ON); 2011. Available from: http://www.ekospolitics.com/articles/0719.pdf
- De Wals P, Deceuninck G, Lefebvre B, et al. Impact of an immunization campaign to control an increased incidence of serogroup B meningococcal disease in one region of Quebec, Canada. Clin Infect Dis. 2017;64(9):1263–1267.
- De Wals P. Meningococcal C vaccines: the Canadian experience. Pediatr Infect Dis J. 2004;23(12 Suppl):S280–S284.
- Quach C, Baclic O. on behalf of the National Advisory Committee on Immunization (NACI). Summary of NACI statement: interim recommendations on the use of pneumococcal vaccines in immunocompetent adults 65 years of age and older. CCDR. 2016;42–12:260–262.
- Baylor NW, Marshall VB. Regulation and testing of vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th ed. Philadelphia (PA): Elsevier; 2013. p. 1427–1453.
- Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol. 2010;17(7):1055–1065.
- Government of Canada [Internet]. Ottawa (ON): Immunization schedules by province and territory. [cited 2019 Mar 30]. Available from: https://www.canada.ca/en/public-health/services/provincial-territorial-immunization-information.html
- Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices—united States, 2018–19 influenza season. MMWR Recomm Rep. 2018;67No. RR–3:1–20.
- Vaudry W, Zhao L. Stirling R on behalf of the National Advisory Committee on Immunization (NACI). Summary of the NACI seasonal influenza vaccine statement for 2018–2019. Can Commun Dis Rep. 2018;446:123–128. .
- Gilca R, De Serres G, Brousseau N, et al. 2018. Révision du Programme d’immunisation contre l’influenza au Québec. Quebec City (QC): Institut national de santé publique. Available from: https://www.inspq.qc.ca/sites/default/files/publications/2415_revision_programme_immunisation_influenza.pdf
- Dubé E, Duval B, Gilca V, et al. Prevention by vaccination of diseases attributable to the human papilloma virus in Quebec. Quebec City (QC): Institut national de Santé publique du Québec; 2008. Available from: https://www.inspq.qc.ca/sites/default/files/publications/783_prev_vph_ang.pdf
- Gouvernement du Québec [Internet]. Quebec City (QCN): Budget des dépenses 2017–2018. [cited 2019 Mar 30]. Available from: https://www.tresor.gouv.qc.ca/fileadmin/PDF/budget_depenses/17-18/renseignementsSupplementaires.pdf
- Canada’s response to the 2009 H1N1 influenza pandemic. Ottawa (ON): The Standing Senate Committee on Social Affairs, Science and Technology, 2010. [cited 2019 Mar 30]. Available from: https://sencanada.ca/content/sen/committee/403/soci/rep/rep15dec10-e.pdf
- Poirier B, De Wals P, Petit G, et al. Cost-effectiveness of a 3-dose pneumococcal conjugate vaccine program in the province of Quebec, Canada. Vaccine. 2009;27(50):7105–7109.
- Mello MM, Abiola S, Colgrove J. Pharmaceutical companies’role in state vaccination policymaking: the case of papillomavirus vaccination. Am J Public Health. 2012;102:893–898.
- Salisbury D. Introduction of a conjugate meningococcal type C vaccine programme in the UK. J Paediatr Child Health. 2001;37(5):S34–S36.
- Government of Canada [Internet]. Ottawa (ON): Federal Trust Funds. [cited 2019 Mar 30]. Available from: https://www.fin.gc.ca/fedprov/ftf-eng.asp
- Kwong JC, Stukel TA, Lim J, et al. The effect of universal influenza immunization on mortality and health care use. PLoS Med. 2008;5(10):e211.
- Demicheli V. Mass influenza vaccination in Ontario: is it worthwhile? CMAJ. 2001;164(1):38–39.
- Christensen H, Trotter CL, Hickman M, et al. Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study. BMJ. 2014;349:g5725.
- Joint Committee on Vaccines and Immunization (JCVI) [Internet]. London (UK): Code of Practice; June 2013. [cited 2019 Mar 30]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/224864/JCVI_Code_of_Practice_revision_2013_-_final.pdf
- Signorelli C, Odone A, Cella P, et al. Childhood vaccine coverage in Italy after the new law on mandatory immunization. Ann Ig. 2018;30(4 Supplement 1):1–10.
- Paterlini M. Italy suspends mandatory vaccination of nursery children after Senate vote. BMJ. 2018;362. DOI:10.1136/bmj.k3506
- Guay M, De Wals P, Jetté L, et al. Utilisation d’un vaccin antipneumococcique conjugué au Québec. Quebec City (QC): Institut national de santé publique du Québec; 2003. Available from: https://www.inspq.qc.ca/publications/210
- Whitney CG, Pilishvili T, Farley MM, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet. 2006;368(9546):1495–1502.
- Comité sur l’immunisation du Québec (CIQ). Assessment of the appropriateness of an immunization program for pneumococcal infections in children using a reduced number of doses of conjugate vaccine. Quebec City (QC): Institut national de santé publique du Québec; 2005. Available from: https://www.inspq.qc.ca/publications/210
- The Vaccines for Children Program (VFC). Washington (DC): National Center for Health Research, 2019. [cited 2019 Mar 30]. Available from: http://www.center4research.org/vaccines-children-program-vfc/
- Lennon D, Reid S, Stewart J, et al. Reducing inequalities with vaccines: New Zealand’s MeNZB vaccine initiative to control an epidemic. J Paediatr Child Health. 2012;48(3):193–201.
- Espinoza-Moya M, Crowcroft N, De Wals P, et al. Factors influencing variation in the decision to move from a HPV 3-dose to a 2-dose routine vaccination program for adolescents in Canada. [Manuscript in preparation].
- Parkhurst JO, Vulimiri M. Cervical cancer and the global health agenda: insights from multiple policy-analysis frameworks. Glob Public Health. 2013;8(10):1093–1108.
- Walhart T. The application of Kingdon’s multiple streams theory for human papillomavirus-related anal intraepithelial neoplasia. J Adv Nurs. 2013;69(11):2413–2422.
- Abiola SE, Colgrove J, Mello MM. The politics of HPV vaccination policy formation in the United States. J Health Polit Policy Law. 2013;38(4):645–681.
- Shapiro GK, Guichon J, Prue G, et al. A multiple streams analysis of the decisions to fund gender-neutral HPV vaccination in Canada. Prev Med. 2017;100:123–131.